Van Cutsem G, Siewe Fodjo J, Hadermann A, Amaral L-J, Trevisan C, Pion S, et al. Onchocerciasis-Associated Epilepsy: charting a path forward. Seizure: European Journal of Epilepsy. 2024;.

Mutono N, Basáñez M-G, James A, Stolk WA, Makori A, Kimani TN, et al. Elimination of transmission of onchocerciasis (river blindness) with long-term ivermectin mass drug administration with or without vector control in sub-Saharan Africa: a systematic review and meta-analysis. The Lancet Global Health [Internet]. 2024;:1-12. Available from: https://www.thelancet.com/action/showPdf?pii=S2214-109X%2824%2900043-3

Masiyiwa T, Bockarie MJ. Ending lymphatic filariasis and onchocerciasis in Africa: Reasons for hope. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases [Internet]. 2024;. Available from: https://www.ijidonline.com/action/showPdf?pii=S1201-9712%2824%2900017-1

Domche A, Nana Djeunga HC, Nwane PB, Njitchouang GR, Nono Fesuh B, Njiokou F, et al. Significant reduction of blackfly densities in persistent onchocerciasis area following pilot implementation of an environment friendly approach (Slash and Clear). Scientific Reports [Internet]. 2024;14(1):1-10. Available from: https://www.nature.com/articles/s41598-023-50747-4.pdf

Mushi V, Mmbando BP, Colebunders R. Integration of onchocerciasis morbidity management and disability prevention services in the healthcare system in Tanzania: a call for action and recommendations. Tropical diseases, travel medicine and vaccines [Internet]. 2024;10(1):1-5. Available from: https://tdtmvjournal.biomedcentral.com/counter/pdf/10.1186/s40794-023-00211-y.pdf

Yirgu R, Middleton J, Fekadu A, Davey G, Bremner S, Jones CI, et al. No secondary impact of ivermectin mass drug administration for onchocerciasis elimination on the prevalence of scabies in northwestern Ethiopia. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2023;.

Shintouo CM, Shey RA, Yengo BN, Yaah NE, Teh RN, Ngwese RA, et al. Effects of the suspension of mass drug administration during the COVID-19 pandemic on onchocerciasis prevalence in the Bandjoun and Massangam health districts, West Region of Cameroon. Acta Tropica. 2023;246.

Eyang-Assengone E-R Unité de Recherche en Ecologie de la Santé (URES), Centre Interdisciplinaire de Recherches Médicales de Franceville (CIRMF), Franceville BP 769, Gabon, Makouloutou-Nzassi P Unité de Recherche en Ecologie de la Santé (URES), Centre Interdisciplinaire de Recherches Médicales de Franceville (CIRMF), Franceville BP 769, Gabon, Département de Biologie et Ecologie Animale, Institut de Recherche en Ecologie Tropicale (IRET/CENAREST), Libreville BP 13354, Gabon, Mbou-Boutambe C Unité de Recherche en Ecologie de la Santé (URES), Centre Interdisciplinaire de Recherches Médicales de Franceville (CIRMF), Franceville BP 769, Gabon, Bangueboussa F Unité de Recherche en Ecologie de la Santé (URES), Centre Interdisciplinaire de Recherches Médicales de Franceville (CIRMF), Franceville BP 769, Gabon, Atsame J Programme de Lutte Contre les Maladies Parasitaires, Ministère de la Santé du Gabon, Libreville BP 2434, Gabon, Boundenga L Unité de Recherche en Ecologie de la Santé (URES), Centre Interdisciplinaire de Recherches Médicales de Franceville (CIRMF), Franceville BP 769, Gabon, Département d’anthropologie, Université de Durham, South Road, Durham DH1 3LE, UK. Status of Onchocerciasis Elimination in Gabon and Challenges: A Systematic Review. Microorganisms [Internet]. 2023;11(8):1-11. Available from: https://www.mdpi.com/2076-2607/11/8/1946/pdf?version=1690634608

Bhwana D, Siewe Fodjo JN, Amaral L-J, Vandevenne L, Francis F, Challe DP, et al. Disability assessment among persons with epilepsy in Mahenge, an onchocerciasis-endemic area in Tanzania: A cross-sectional study. Epilepsy & Behavior. 2023;146:109367.